dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
Published 4 years ago • 121 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:41
dr. goldberg on pd-l1 as a biomarker in lung cancer
-
1:04
dr. lilenbaum on the promising future direction of immunotherapy in lung cancer
-
1:12
dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
1:42
dr. gandara discusses pd-l1 as a biomarker in lung cancer
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
9:54
is the pd-l1 biomarker ready for prime time?
-
1:49
immunotherapy and beyond for lung cancer prevention
-
2:24
dr. weiss on pd-l1 biomarker in lung cancer
-
5:06
should pd-l1 be used as a biomarker for immunotherapy in lung cancer?
-
0:51
dr. rizvi on pd-l1 as a biomarker for immunotherapy agents in lung cancer
-
1:33:59
revisiting pd-l1 as an immunotherapy biomarker across the cancer spectrum
-
3:50
the role of pd-l1: is it accurate enough as a biomarker for immunotherapy response?
-
3:50
pd-l1 expression in nsclc
-
1:03
dr. barbara j. gitlitz on why pd-l1 is not a good biomarker for immunotherapy in lung cancer
-
6:21
lung cancer video library - pdl1 as a biomarker for first line
-
4:50
nsclc: challenges with pd-l1 as biomarker
-
4:47
pd-l1 biomarker testing
-
10:20
pd-l1 testing in advanced lung cancer